Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.7.0 was added to the page, signaling a new revision of the study record. This update appears to be a maintenance/version update rather than a change to study details or results.SummaryDifference19%

- Check39 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor metadata update to the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study record’s update log was modified to add August 2026 entries and October/December 2026 entries while removing earlier dates, indicating administrative maintenance of the record rather than substantive content changes.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, signaling a small page or backend update. This revision does not appear to alter the study details or data presented on the page.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows a revision string updated from v3.6.3 to v3.6.4, indicating an underlying site update rather than a change to the study data or text.SummaryDifference0.1%

- Check96 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3, reflecting a behind-the-scenes platform update to the page. This indicates a minor software release rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.